Journal article
Prevention of Atrial Fibrillation With Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers A Meta-Analysis
Abstract
OBJECTIVES: This study was designed to identify all randomized clinical trial data evaluating angiotensin-converting enzyme inhibitors or angiotensin receptor blockers for the prevention of atrial fibrillation (AF), to estimate the magnitude of this effect and to identify patient subgroups most likely to benefit.
BACKGROUND: Angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) reduce morbidity and mortality …
Authors
Healey JS; Baranchuk A; Crystal E; Morillo CA; Garfinkle M; Yusuf S; Connolly SJ
Journal
Journal of the American College of Cardiology, Vol. 45, No. 11, pp. 1832–1839
Publisher
Elsevier
Publication Date
June 2005
DOI
10.1016/j.jacc.2004.11.070
ISSN
0735-1097